Citadel Advisors’s Biodexa Pharmaceuticals BDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-134
| Closed | -$30K | – | 5822 |
|
|
2024
Q2 | $30K | Buy |
+134
| New | +$30K | ﹤0.01% | 5315 |
|
|
2022
Q1 | – | Hold |
0
| – | -$44K | – | 6342 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6189 |
|
|
2021
Q3 | – | Hold |
0
| – | -$54K | – | 6382 |
|
|
2021
Q2 | – | Hold |
0
| – | -$301K | – | 6179 |
|
|
2021
Q1 | – | Hold |
0
| – | -$32K | – | 5037 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4925 |
|
|
2019
Q1 | – | Hold |
0
| – | -$19K | – | 4528 |
|
|
2018
Q4 | – | Hold |
0
| – | -$15K | – | 4283 |
|
|
2018
Q3 | – | Hold |
0
| – | -$19K | – | 4175 |
|
|
2018
Q2 | – | Hold |
0
| – | -$12K | – | 4054 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3905 |
|
|
2017
Q4 | – | Hold |
0
| – | -$18K | – | 3863 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3535 |
|